Merck
-
Merck donates five mobile compact labs for detecting counterfeit medicines to Zambia
To help improve health care in Zambia, the Global Pharma Health Fund, a charitable initiative funded by Merck, has donated five mobile compact laboratories to the Health Ministry in the capital city of Lusaka to help detect counterfeit medicines.
Merck | 24 April 2012
-
Merck receives European approval to expand use of Rebif
Merck announced that the European Commission (EC) has approved extension of the indication of Rebif (interferon beta-1a), its treatment for relapsing forms of multiple sclerosis (MS).
Merck | 02 March 2012
-
Merck appoints heads of corporate auditing, corporate strategy
Merck announced that Friederike Rotsch has been appointed head of corporate auditing. She reports to Karl-Ludwig Kley, chairman of the executive board of Merck. At the same time, the company announced that Isabel De Paoli will assume the leadership of corporate strategy. She too will report directly to Kley.
Merck | 10 January 2012
-
Vorapaxar’s data presented at AHA, published in NEJM
Researchers presented and published results from TRACER (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome), the first clinical outcomes trial of vorapaxar, the investigational Protease Activated Receptor 1 (PAR-1) thrombin receptor antagonist from Merck (known as MSD outside the US and Canada).
Merck | 18 November 2011
-
Merck, Serum Institute to develop and expand access to pneumococcal conjugate vaccine
Merck and Serum Institute of India Limited announced an agreement to work together to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in the emerging and developing world countries. It is estimated that one out of every two c…
Merck | 04 August 2011
-
Merck and Simcere to establish China joint venture
Merck & Co Inc and China’s Simcere Pharmaceutical Group announced the signing of a framework agreement to establish a joint venture focused on serving China's rapidly expanding health care needs by providing significantly improved access to quality…
Merck | 25 July 2011
-
Merck and Simcere to establish China joint venture
Merck & Co Inc and China's Simcere Pharmaceutical Group announced the signing of a framework agreement to establish a joint venture focused on serving China's rapidly expanding health care needs by providing significantly improved access to quality m…
Merck | 01 July 2011
-
Merck and Hanwha Chemical establish global strategic collaboration
Collaboration to develop and commercialize candidate biosimilar form of Enbrel.
Merck | 14 June 2011
-
Roche, Merck establish strategic agreements in hepatitis C fight
Non-exclusive agreements focused on improving treatment, diagnosis and awareness of chronic hepatitis C for patients.
Merck | 17 May 2011
-
Merck Millipore opens new facility in Shanghai
Merck Millipore, the Life Science division of Merck, has opened its Biopharmaceutical Technical and Training Center in Shanghai, China. The 2,500 square meter facility will provide support, training and validation services to Merck Millipore’s biop…
Merck | 13 May 2011
